Cytogen Corporation - PharmaTrack

Research and Markets (researchandmarkets.com/reports/c10475) has announced the addition of Cytogen Corporation - PharmaTrack to their offering.

(PRWEB) December 4, 2004 -- PharmaTrack is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that dont have adequate analyst coverage, making it a high-in-demand, value added research product. This report profiles Cytogen Corporation.

Each PharmaTrack Profile is packed with crucial data & information and in-depth analysis. The profile elaborates on the companys business structure and operations, products and services. It extensively discusses the companys financial performance and strategic imperatives from an investors perspective and provides a reliable outlook for the future.

Scope of the Report
- Provides key company data and analysis to industry players, which is vital to enhance business and competitor intelligence and facilitate decision making
- Analyzes the industry and the segment to which the company belongs in a concise manner.
- Compares the company vis-à-vis its peers in a detailed manner
- Discusses also the current industry status and the significant trends that influence the industry
- Tracks key initiatives of the company in the recent period across strategic areas of focus
- Analyzes the Strengths & Weaknesses of the company (SWOT Analysis)
- Analyzes the financial performance of the company for the most recently ended quarter and financial year across businesses, product/service categories and revenue streams
- Scopes comment on the companys outlook for the forthcoming period -- strategic and financial
- Supplementary information such the key industry players, overall industry financial and market performance, companys board members and senior management team, company and business overview, list of products and services, and stock movements for annual and three-year periods.

Company Brief 1

Key Highlights 1
- Stock Data -- Last 3 years to date 2
- Stock Data -- Last 52 weeks 2

Industry Overview 3

Company Overview 13

Management Board 14

Shareholding Pattern 14
- Insider Ownership 14
- Institutional Ownership 15
- Public 15

Major Operations 15
- Manufacturing & R&D Base 15
- Markets and Segments 16
- Ongoing Clinical Trials 16

Key Partnerships 16

Market Position -- Comparison with Industry Peers 18

Strategic Overview 19
- SWOT Analysis 19

Strategic Focus 26
- Enhanced Focus on Oncology Market 26
- Intensified Marketing Efforts 27
- Expanding Product Portfolio & Product Indications 27

Financial Performance 29
- 2004 Second Quarter Performance 29
- Full --Year Performance 31

Risk Factors 34

Outlook 35

For more information visit http://www.researchandmarkets.com/reports/c10475

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980

###